Back to GetFilings.com



 

UNITED STATES SECURITIES AND EXCHANGE

COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

 

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the quarterly period ended April 3, 2004

 

 

 

OR

 

 

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the transition period from                                  to                                 

 

Commission file number 000-18032

 

LATTICE SEMICONDUCTOR CORPORATION

(Exact name of Registrant as specified in its charter)

 

State of Delaware

 

93-0835214

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

5555 N.E. Moore Court, Hillsboro, Oregon

 

97124-6421

(Address of principal executive offices)

 

(Zip Code)

 

 

 

(503) 268-8000

(Registrant’s telephone number, including area code)

 


 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ý  No o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).  Yes ý  No o

 

At May 6, 2004, there were 113,125,757 shares of the Registrant’s common stock, $.01 par value, outstanding.

 

 

The information contained in this Form 10-Q is as of May 12, 2004. This Form 10-Q should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2003.

 

 



 

LATTICE SEMICONDUCTOR CORPORATION

 

INDEX

 

PART I.     FINANCIAL INFORMATION

 

 

 

 

Item 1.

Financial Statements (Unaudited)

 

 

 

 

 

Condensed Consolidated Statement of Operations – Three Months Ended March 31, 2004 and March 31, 2003

 

 

 

 

 

Condensed Consolidated Balance Sheet – March 31, 2004 and December 31, 2003

 

 

 

 

 

Condensed Consolidated Statement of Cash Flows – Three Months Ended March 31, 2004 and March 31, 2003

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

 

 

Item 4.

Controls and Procedures

 

 

 

 

PART II.     OTHER INFORMATION

 

 

 

 

Item 2.

Changes In Securities, Use of Proceeds and Issue Purchases of Equity Securities

 

 

 

 

Item 6.

Exhibits and Reports on Form 8-K

 

 

 

 

 

Signatures

 

 

 

Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act.  Any statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking.  We use words or phrases such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “projects,” “may,” “will,” “should,” “continue,” “ongoing,” “future,” “potential” and similar words or phrases to identify forward-looking statements.

 

Forward-looking statements involve estimates, assumptions, risks and uncertainties that could cause actual results to differ materially from those expressed in them.  Among the key factors that could cause our actual results to differ materially from the forward-looking statements are delay in product or technology development, change in economic conditions of the various markets we serve, lack of market acceptance or demand for our new products, dependencies on silicon wafer suppliers and semiconductor assemblers, the impact of competitive products and pricing, opportunities or acquisitions that we pursue, the availability and terms of financing, and the other risks that are described herein and that are otherwise described from time to time in our filings with the Securities and Exchange Commission, including but not limited to the items discussed in “Factors Affecting Future Results” set forth in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2 of this report. You should not unduly rely on forward-looking statements because our actual results could materially differ from those expressed in any forward-looking statements made by us.  Further, any forward-looking statement applies only as of the date on which it is made.  We are not required to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events.

 

2



 

PART I.  FINANCIAL INFORMATION

 

ITEM 1.  FINANCIAL STATEMENTS

 

LATTICE SEMICONDUCTOR CORPORATION

 

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(In thousands, except per share data)

(unaudited)

 

 

 

Three Months Ended

 

 

 

March 31,
2004

 

March 31,
2003

 

 

 

 

 

 

 

Revenue

 

$

59,071

 

$

57,297

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

Cost of products sold

 

24,719

 

23,028

 

Research and development

 

22,259

 

21,832

 

Selling, general and administrative

 

13,087

 

12,483

 

Amortization of intangible assets (1)

 

18,654

 

21,114

 

 

 

 

 

 

 

Total costs and expenses

 

78,719

 

78,457

 

 

 

 

 

 

 

Loss from operations

 

(19,648

)

(21,160

)

 

 

 

 

 

 

Other income, net

 

3,107

 

1,491

 

 

 

 

 

 

 

Loss before benefit for income taxes

 

(16,541

)

(19,669

)

 

 

 

 

 

 

Benefit for income taxes

 

 

 

 

 

 

 

 

 

Net loss

 

$

(16,541

)

$

(19,669

)

 

 

 

 

 

 

Basic net loss per share

 

$

(0.15

)

$

(0.18

)

 

 

 

 

 

 

Diluted net loss per share

 

$

(0.15

)

$

(0.18

)

 

 

 

 

 

 

Shares used in per share calculations:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

112,627

 

111,390

 

 

 

 

 

 

 

Diluted

 

112,627

 

111,390

 

 


(1)         Includes $806 and $3,270 of amortization of deferred stock compensation expense for the three months ended March 31, 2004 and March 31, 2003, respectively, attributable to Research and Development activities.

 

See Accompanying Notes to Condensed Consolidated Financial Statements

 

3



 

LATTICE SEMICONDUCTOR CORPORATION

 

CONDENSED CONSOLIDATED BALANCE SHEET

(In thousands, except share and par value data)

 

 

 

 

March 31,
2004

 

December 31,
2003

 

 

 

(unaudited)

 

 

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

41,603

 

$

35,276

 

Short-term investments

 

256,945

 

242,474

 

Accounts receivable, net

 

26,013

 

26,796

 

Inventories

 

44,312

 

46,630

 

Other current assets

 

57,575

 

51,537

 

 

 

 

 

 

 

Total current assets

 

426,448

 

402,713

 

 

 

 

 

 

 

Foundry investments, advances and other assets

 

74,293

 

86,883

 

Property and equipment, net

 

51,313

 

53,800

 

Intangible assets, net

 

66,789

 

84,627

 

Goodwill

 

223,595

 

223,605

 

 

 

 

 

 

 

 

 

$

842,438

 

$

851,628

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable and accrued expenses

 

$

31,729

 

$

28,500

 

Deferred income on sales to distributors

 

13,847

 

10,564

 

Income taxes payable

 

126

 

37

 

 

 

 

 

 

 

Total current liabilities

 

45,702

 

39,101

 

 

 

 

 

 

 

Zero Coupon Convertible Subordinated notes due in 2010

 

184,000

 

184,000

 

Other long-term liabilities

 

22,699

 

22,415

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $.01 par value, 10,000,000 shares authorized; none issued or outstanding

 

 

 

Common stock, $.01 par value, 300,000,000 shares authorized, 113,115,579 and 113,047,874 shares issued and outstanding

 

1,131

 

1,130

 

Paid-in capital

 

587,598

 

586,834

 

Deferred stock compensation

 

(4,580

)

(5,444

)

Accumulated other comprehensive income

 

19,040

 

20,203

 

Retained earnings (deficit)

 

(13,152

)

3,389

 

 

 

 

 

 

 

Total stockholders’ equity

 

590,037

 

606,112

 

 

 

 

 

 

 

 

 

$

842,438

 

$

851,628

 

 

See Accompanying Notes to Condensed Consolidated Financial Statements.

 

4



 

LATTICE SEMICONDUCTOR CORPORATION

 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(In thousands)

(unaudited)

 

 

 

Three Months Ended

 

 

 

March 31,
2004

 

March 31,
2003

 

 

 

 

 

 

 

Cash flows from operating activities:

 

 

 

 

 

Net loss

 

$

(16,541

)

$

(19,669

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

 

Depreciation and amortization

 

24,499

 

26,545

 

Gain on sale of UMC shares

 

(2,536

)

 

Gain on retirement of convertible notes

 

 

(2,923

)

Changes in assets and liabilities:

 

 

 

 

 

Accounts receivable

 

783

 

(4,277

)

Inventories

 

2,318

 

4,365

 

Other current assets

 

(2,043

)

(525

)

Foundry investments, advances and other assets

 

218

 

(580

)

Accounts payable and accrued expenses

 

3,274

 

3,574

 

Deferred income

 

3,283

 

1,953

 

Income taxes payable

 

89

 

(142

)

Other liabilities

 

(313

)

(375

)

 

 

 

 

 

 

Total adjustments

 

29,572

 

27,615

 

 

 

 

 

 

 

Net cash provided by operating activities

 

13,031

 

7,946

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

Proceeds from short-term investments

 

30,344

 

112,568

 

Purchase of short-term investments

 

(44,815

)

(223,956

)

Proceeds from sale of equity securities

 

9,250

 

 

Capital expenditures

 

(2,011

)

(3,211

)

 

 

 

 

 

 

Net cash used by investing activities

 

(7,232

)

(114,599

)

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Retirement of convertible debt

 

 

(29,570

)

Net proceeds from issuance of common stock

 

528

 

802

 

 

 

 

 

 

 

Net cash (used in) provided by financing activities

 

528

 

(28,768

)

 

 

 

 

 

 

Net Increase (decrease) in cash and cash equivalents

 

6,327

 

(135,421

)

 

 

 

 

 

 

Beginning cash and cash equivalents

 

35,276

 

169,475

 

 

 

 

 

 

 

Ending cash and cash equivalents

 

$

41,603

 

$

34,054

 

 

 

 

 

 

 

Supplemental disclosures of non-cash investing and financing activities:

 

 

 

 

 

Unrealized (loss) gain on (depreciation) appreciation of foundry investments included in other comprehensive income

 

$

870

 

$

(5,034

)

 

See Accompanying Notes to Condensed Consolidated Financial Statements.

 

5



 

LATTICE SEMICONDUCTOR CORPORATION

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

Note 1 - Basis of Presentation:

 

The accompanying consolidated financial statements are unaudited and have been prepared by Lattice Semiconductor Corporation (“the Company”) pursuant to the rules and regulations of the Securities and Exchange Commission and in our opinion include all adjustments, consisting only of normal recurring adjustments, necessary for the fair statement of results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. These consolidated financial statements should be read in conjunction with our audited financial statements and notes thereto included in our annual report on Form 10-K for the year ended December 31, 2003.

 

The preparation of financial statements in conformity with generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the fiscal periods presented. Actual results could differ from these estimates.

 

We report based on a 52 or 53 week year ending on the Saturday closest to December 31. For ease of presentation, we have adopted the convention of using March 31, June 30, September 30 and December 31 as period end dates for all financial statement captions.

 

This Quarterly Report on Form 10-Q contains forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Actual results could differ materially from those projected in the forward-looking statements as a result of the factors, set forth in the section entitled “Factors Affecting Future Results” and elsewhere in this report.

 

Note 2 - Revenue Recognition:

 

Revenue from sales to OEM customers is recognized upon shipment provided that persuasive evidence of an arrangement exists, the price is fixed and determinable, title has transferred, collection of resulting receivables is probable, there are no customer acceptance requirements and no remaining significant obligations.  Certain of our sales are made to distributors under agreements providing price protection and right of return on unsold merchandise.  Revenue and cost relating to such distributor sales are deferred until either the product is sold by the distributor or return privileges and price protection rights terminate, and related estimated revenue and estimated

costs are then reflected in income.  Revenue from software sales was not material for the periods presented.

 

Note 3 – Net Income Per Share:

 

Net income per share is computed based on the weighted average number of shares of common stock and potentially dilutive securities assumed to be outstanding during the period using the treasury stock method. Potentially dilutive securities consist of stock options, warrants to purchase common stock and convertible subordinated notes.

 

The most significant difference between the computation of basic and diluted net income per share is that basic net income per share does not treat potentially dilutive securities such as stock options, warrants and convertible subordinated notes as outstanding.  For all periods presented, the computation of net loss per share excludes the effect of our stock options, warrants and convertible notes, as they were antidilutive. A reconciliation of basic and diluted net income per share is presented below (in thousands, except for per share data):

 

6



 

 

 

Three months ended

 

 

 

Mar. 31,
2004

 

Mar. 31,
2003

 

 

 

 

 

 

 

Net loss

 

$

(16,541

)

$

(19,669

)

 

 

 

 

 

 

Shares used in basic net loss per share calculations

 

112,627

 

111,390

 

 

 

 

 

 

 

Dilutive effect of stock options and warrants

 

 

 

 

 

 

 

 

 

Shares used in diluted net loss per share

 

112,627

 

111,390

 

 

 

 

 

 

 

Basic net loss per share

 

$

(0.15

)

$

(0.18

)

 

 

 

 

 

 

Diluted net loss per share

 

$

(0.15

)

$

(0.18

)

 

Stock-Based Compensation

 

We account for our employee and director stock options and employee stock purchase plan in accordance with provisions of Accounting Principles Board Opinion No. 25 (“APB 25”), “Accounting for Stock Issued to Employees.” Pro forma disclosures as required under SFAS 123, “Accounting for Stock-Based Compensation” and as amended by SFAS 148, “Accounting for Stock-Based Compensation – Transition and Disclosure,” are presented below. Pursuant to FASB Interpretation No. 44  “Accounting for Certain Transactions Involving Stock Based Compensation – an interpretation of APB Opinion No. 25,” effective July 1, 2000, the “in the money” portion of stock options granted to employees in connection with acquisitions is accounted for as Deferred Stock Compensation in Stockholders’ Equity and amortized to operations as part of Amortization of Intangible Assets over the vesting periods of the options.

 

The fair value of our stock-based employee compensation cost for purposes of our pro forma disclosures was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions:

 

 

 

Grants for quarter ended

 

 

 

Mar. 31,
2004

 

Mar. 31,
2003

 

Stock options:

 

 

 

 

 

Expected volatility

 

53.8

%

58.1

%

Risk-free interest rate

 

2.3

%

2.1

%

Expected life from vesting date

 

1.6 years

 

1.6 years

 

Dividend yield

 

0

%

0

%

 

The Black-Scholes option pricing model was developed for use in estimating the fair value of freely tradable, fully transferable options without vesting restrictions. Our stock options have characteristics which differ significantly from those of freely tradable, fully transferable options. The Black-Scholes option pricing model also requires highly subjective assumptions, including expected stock price volatility and expected stock option term which greatly affect the calculated fair value of an option.  Our actual stock price volatility and option term may be materially different from the assumptions used herein.

 

The resultant grant date weighted-average fair values calculated using the Black-Scholes option pricing model and the noted assumptions for stock options granted was $4.45 and $1.23 for the first quarters of 2004 and 2003, respectively. For purposes of pro forma disclosures, the estimated fair value of the options is amortized to expense over the options’ vesting period.

 

7



 

Our pro forma information is as follows (in thousands, except per share data):

 

 

 

Quarter
ended
Mar. 31,
2004

 

Quarter
ended
Mar.  31,
2003

 

 

 

 

 

 

 

Net loss, as reported

 

$

(16,541

)

$

(19,669

)

Add: Stock based employee compensation expense included in reported loss

 

806

 

3,270

 

Deduct:    Total stock-based employee compensation expense determined under fair value based method for all awards

 

(5,033

)

(7,431

)

Pro forma net loss

 

$

(20,768

)

$

(23,830

)

 

 

 

 

 

 

Net loss per share:

 

 

 

 

 

Basic-as reported

 

$

(0.15

)

$

(0.18

)

Basic- pro forma

 

$

(0.18

)

$

(0.21

)

 

 

 

 

 

 

Diluted-as reported

 

$

(0.15

)

$

(0.18

)

Diluted-pro forma

 

$

(0.18

)

$

(0.21

)

 

Note 4 - Inventories (in thousands):

 

 

 

Mar. 31,
2004

 

Dec. 31,
2003

 

Work in progress

 

$

31,137

 

$

34,327

 

Finished goods

 

13,175

 

12,303

 

 

 

$

44,312

 

$

46,630

 

 

Note 5 - Changes in Stockholders’ Equity (in thousands):

 

 

 

Common
Stock

 

Paid-in
Capital

 

Deferred
Stock
Comp.

 

Accumulated
Other
Comprehensive
Income

 

Retained
Earnings
(Deficit)

 

Total

 

Balances, Dec. 31, 2003

 

$

1,130

 

$

586,834

 

$

(5,444

)

$

20,203

 

$

3,389

 

$

606,112

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued

 

1

 

822

 

 

 

 

823

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized gain on equity securities (Note 9)

 

 

 

 

1,075

 

 

1,075

 

Recognized gain on sale of UMC stock (Note 9)

 

 

 

 

 

 

 

(2,219

)

 

 

(2,219

)

Deferred stock compensation

 

 

(58

)

58

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of deferred stock compensation

 

 

 

806

 

 

 

806

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Translation adjustment

 

 

 

 

(19

)

 

(19

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss for the three-month period

 

 

 

 

 

(16,541

)

(16,541

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances, Mar. 31, 2004

 

$

1,131

 

$

587,598

 

$

(4,580

)

$

19,040

 

$

(13,152

)

$

590,037

 

 

Total comprehensive loss for the first three-month period of 2004 was $17.7 million and substantially comprises a $16.5 million net loss from operations and a $1.1 million net gain related to equity investments.

 

8



 

Note 6 – Goodwill and Purchased Intangible Assets

 

As a result of adopting SFAS 142 “Intangible Assets” in 2002, goodwill and certain intangibles with indefinite lives are no longer being amortized.To apply SFAS 142, a company is divided into separate “reporting units,” each representing groups of products that are separately managed.  For this purpose, we have one reporting unit.  To determine whether or not goodwill may be impaired, a test is required comparing the book value of the “reporting unit” to its trading price. Similar tests are required in the future, at least annually, and more often where there is a change in circumstances that could result in an impairment of goodwill.  If the trading price of our common stock is below the book value for a sustained period, a goodwill impairment test will be performed by comparing book value to estimated market value (trading price plus a control premium).  The excess of book value over estimated market value will then be subtracted from the goodwill account with a resulting charge to operations. Subsequent unrealized recoveries in market value, if any, will not be recorded.  We completed our annual goodwill impairment assessment in December 2003, upon which no impairment charge was recorded. Additional goodwill impairment tests will be performed at least annually.

 

The following tables present details of the Company’s total purchased intangible assets (in millions):

 

March 31, 2004

 

Gross

 

Accumulated
amortization

 

Net

 

 

 

 

 

 

 

 

 

Current technology

 

$

273.6

 

$

(227.8

)

$

45.8

 

Core technology

 

7.3

 

(2.3

)

5.0

 

Licenses

 

10.2

 

(3.2

)

7.0

 

Non-compete agreements

 

14.3

 

(10.3

)

4.0

 

Workforce

 

4.7

 

(1.5

)

3.2

 

Backlog

 

1.4

 

(1.4

)

 

Customer list

 

17.4

 

(16.7

)

0.7

 

Patents and trademarks

 

26.8

 

(25.7

)

1.1

 

 

 

 

 

 

 

 

 

Total

 

$

355.7

 

$

(288.9

)

$

66.8

 

 

 

December 31, 2003

 

Gross

 

Accumulated
amortization

 

Net

 

 

 

 

 

 

 

 

 

Current technology

 

$

273.6

 

$

(214.4

)

$

59.2

 

Core technology

 

7.3

 

(1.9

)

5.4

 

Licenses

 

10.2

 

(2.9

)

7.3

 

Non-compete agreements

 

14.3

 

(9.2

)

5.1

 

Workforce

 

4.7

 

(1.2

)

3.5

 

Backlog

 

1.4

 

(1.4

)

 

Customer list

 

17.4

 

(15.8

)

1.6

 

Patents and trademarks

 

26.8

 

(24.3

)

2.5

 

 

 

 

 

 

 

 

 

Total

 

$

355.7

 

$

(271.1

)

$

84.6

 

 

The estimated future amortization expense of purchased intangible assets as of March 31, 2004 is as follows (in millions):

 

Fiscal Year:

 

Amount

 

 

 

 

 

2004 (remaining nine months)

 

$

26.0

 

2005

 

14.4

 

2006

 

10.8

 

2007

 

9.8

 

2008

 

5.8

 

 

 

$

66.8

 

 

9



 

The estimated future amortization expense of deferred stock compensation attributable to Research and Development activities as of March 31, 2004 is approximately $2.6 million for the remainder of 2004 and approximately $1.9 million for 2005.

 

Note 7 - New Accounting Pronouncements:

 

In January 2003, the Financial Accounting Standards Board (“FASB”) issued Financial Standards Accounting Board Interpretation (“FIN”) No. 46, “Consolidation of Variable Interest Entities,” an interpretation of Accounting Research Bulletin No. 51, “Consolidated Financial Statements.” FIN 46 establishes accounting guidance for consolidation of a variable interest entity.  In a variable interest entity the equity investors do not have a controlling interest or their equity interest is insufficient to finance the entity’s activities without receiving additional subordinated financial support from the other parties.  We do not currently have any business relationship with a variable interest entity, so the adoption of FIN 46 had no impact on our consolidated financial position or results of operations.

 

In May 2003, the FASB issued SFAS 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity.” This pronouncement establishes standards for how an issuer classifies and measures in its statement of financial position certain financial instruments with characteristics of both liabilities and equity. It requires that an issuer classify a financial instrument that is within its scope as a liability (or an asset in certain circumstances) because that financial instrument embodies an obligation of the issuer. SFAS 150 is effective for financial instruments entered into or modified after May 31, 2003, and otherwise is effective for interim periods beginning after June 15, 2003.  On November 7, 2003, FASB issued FASB Staff Position No. FAS 150-3 (“FSP 150-3”), “Effective Date, Disclosures, and Transition for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests under FASB Statement No. 150, Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity.”  FSP 150-3 deferred certain aspects of SFAS 150.  The adoption of SFAS 150 and FSP 150-3 did not have a material impact on our results of operations, financial position or cash flows.

 

In March 2004, the Emerging Issues Task Force finalized its consensus on EITF Issue 03-6, “Participating Securities and the Two-Class Method Under FASB Statement No. 128, Earnings Per Share” (EITF 03-6). EITF 03-6 clarifies what constitutes a participating security and requires the use of the two-class method for computing basic earnings per share when participating convertible securities exist. EITF 03-6 is effective for fiscal periods beginning after March 31, 2004. We are currently analyzing the impact of adoption of EITF 03-6 on our consolidated financial statements.

 

In April 2004, the Financial Accounting Standards Board issued FASB Staff Position (FSP)129-1, “Disclosure Requirements under FASB Statement 129, Disclosure of Information about Capital Structure, Relating to Contingently Convertible Securities”, further defining disclosure requirements for convertible notes, among other things.  As a result of adopting FSP 129-1, we further described circumstances under which note holders may convert their notes into our common shares before note maturity.

 

Note 8 - Legal Matters:

 

We are exposed to certain asserted and unasserted potential claims. There can be no assurance that, with respect to potential claims made against us, that we could resolve such claims under terms and conditions that would not have a material adverse effect on our financial position, cash flows or results of operations.

 

Note 9 – Foundry Investments:

 

In 1995, we entered into a series of agreements with United Microelectronics Corporation (“UMC”), a public Taiwanese company, pursuant to which we agreed to join UMC and several other companies to form a separate Taiwanese corporation, (“UICC”), for the purpose of building and operating an advanced semiconductor manufacturing facility in Taiwan, Republic of China.  Under the terms of the agreements, we invested  $49.7 million for an approximate 10% equity interest in the corporation and the right to receive a percentage of the facility’s wafer production at market prices.

 

In 1996, we entered into an agreement with Utek Corporation (“Utek”), a public Taiwanese company in the wafer foundry business that became affiliated with the UMC group in 1998, pursuant to which we agreed to make a series of equity investments in Utek under specific terms. In exchange for these investments, we received the right to purchase a percentage of Utek’s wafer production. Under this agreement, we invested $17.5 million. On January 3, 2000, UICC and Utek merged into UMC.

 

As of March 31, 2004, we owned 81.7 million shares of UMC common stock of which approximately 23.3 million are restricted from sale for more than one year by the terms of our agreement with UMC.  Under the terms of the

 

10



 

UMC agreement, if we sell any of these restricted shares, our rights to guaranteed wafer capacity at UMC may be reduced on a pro-rata basis based on the number of shares that we sell.  If we sell over 10.1 million of these restricted shares, we may lose all of our rights to guaranteed wafer capacity at UMC.

 

For financial reporting purposes, all of our UMC shares are accounted for as available for sale and marked to market in our Consolidated Balance Sheet until they are sold, at which time a gain or loss is recognized in our Consolidated Statement of Operations.  Unrealized gains and losses are included in Accumulated other comprehensive (loss) income within Stockholders’ Equity.  An other than temporary impairment of UMC share value could result in a reduction of the Consolidated Balance Sheet carrying value and would result in a charge to our Consolidated Statement of Operations.

 

The carrying value of our investment in UMC was $73.2 million and $81.1 million at March 31, 2004 and December 31, 2003, respectively, and this balance is classified as part of Other current assets  ($35.8 million and $35.4 million at March 31, 2004 and December 31, 2003, respectively) and Foundry investments, advances and other assets.  During the first quarter of 2004, we sold 10 million UMC shares for a gain of $2.6 million of which $2.2 million was already recorded as an unrealized gain in Accumulated Other Comprehensive Income.  Also in the first quarter of 2004, we recorded a $0.9 million change in unrealized gain related the market value of our UMC shares.  If we liquidate our UMC shares, it is likely that the amount of any future realized gain or loss will be different from the accounting gain or loss reported in prior periods.  (See Note 12.)

 

Note 10 – Segment and Geographic Information:

 

We operate in one industry segment comprising the design, development, manufacture and marketing of high performance programmable logic devices. Our sales by major geographic area were as follows (in thousands):

 

 

 

Three Months Ended

 

 

 

Mar. 31,
2004

 

Mar. 31,
2003

 

 

 

 

 

 

 

United States

 

$

19,695

 

$

18,482

 

Export sales:

 

 

 

 

 

Europe

 

14,197

 

17,409

 

Asia Pacific (other than Japan)

 

16,881

 

12,861

 

Japan

 

6,822

 

5,627

 

Other

 

1,476

 

2,918

 

 

 

39,376

 

38,815

 

 

 

$

59,071

 

$

57,297

 

 

Resale of product through two distributors accounted for 18% and 14% of revenue in the first quarter of 2004, and 21% and 14%, respectively, for the first quarter of 2003. More than 90% of our property and equipment is located in the United States. Other long-lived assets located outside the United States consist primarily of foundry investments and advances.

 

Note 11 - Stock Option Exchange Program

 

On March 14, 2003, we completed an exchange offer related to a stock option exchange program. Under the exchange offer, eligible employees had the opportunity to tender for cancellation certain stock options in exchange for new options to be granted at least six months and one day after the cancellation of the tendered options. Each eligible participant received new options to purchase four shares of common stock for every seven shares subject to options submitted for cancellation. We accepted options to purchase 11.2 million shares for exchange at various exercise prices between $6.30 and $32.25 and granted new options to purchase 6.4 million shares on September 18, 2003, the new grant date. The exercise price per share of the new options of $8.21 was equal to the fair market value of our common stock on the new grant date. In connection with the stock option exchange program, we accelerated the write-off of accrued deferred compensation recorded in conjunction with certain of our acquisitions, due to the cancellation of certain assumed in-the-money stock options. Such acceleration resulted in $2.2 million of additional intangible asset amortization expense in the first quarter of 2003. However, we do not expect to record any additional compensation expense as a result of the exchange program.

 

Note 12 - Subsequent Events:

 

In April 2004, we sold 10.0 million of our unrestricted UMC shares (see Note 9) for $9.6 in cash, resulting in a gain of $3.1 million.  This gain will be reflected in Other Income, net, in our consolidated financial statements for the quarter ended June 30, 2004.

 

11



 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION

 

Lattice Semiconductor Corporation designs, develops and markets high performance programmable logic devices, or PLDs, and related software. Programmable logic devices are widely used semiconductor components that can be configured by the end customer as specific logic circuits, and enable the end customer to shorten design cycle times and reduce development costs.  Our end customers are primarily original equipment manufacturers in the communications, computing, industrial, automotive, medical, consumer and military end markets.

 

Overview of March 31, 2004 Quarter

 

Revenue for our business in the first quarter of 2004 grew to $59.1 million as compared to $57.3 million in the first quarter of 2003 primarily due to growth of our FPGA products of  $3.0 million partially offset by a decline in the sales of SPLD products of  $0.8 million and a decline in the sales of CPLD products of $0.4 million.  The improvement in business conditions first seen in the fourth quarter of 2003 continued through the first quarter of 2004.  This improvement is attributable to general strengthening in the PLD market and improvement in the communications end market.  Future revenue growth is dependent on, among other things, continued favorable business conditions in our end markets and market acceptance of our new products.

 

Our gross margin declined in the first quarter of 2004 to 58.2% from 59.8% in the first quarter of 2003 due to factors including lower production yields and declining average selling prices on our new products.

 

Research and development expenses increased to $22.3 million (37.7% of revenue) in the first quarter of 2004 compared to $21.8 million (38.1% of revenue) in the first quarter of 2003.  There were no significant cost changes in the major categories of research and development expense between the two quarters.  The majority of research and development spending is related to the continued development of next generation FPGA products.  We expect research and development spending in the second half of 2004 to increase by up to $2 million per quarter from present levels due to increased development costs related to the planned introduction of our next generation FPGA products.

 

Selling, general and administrative expenses were $13.1 million in the first quarter of 2004 (22.2% of revenue) as compared to $12.5 million in the first quarter of 2003 (21.8% of revenue) and increased primarily due to marketing expenses related to new products.  To the extent our revenues continue to grow, we expect that there will be a less than proportionate increase in our selling general and administrative expenses.

 

Amortization of intangible assets was $18.7 million in the first quarter of 2004.  Amortization of intangible assets acquired in the Vantis acquisition will be completed during the June 30, 2004 quarter.  As a result, amortization will decline by approximately $1.5 million in the June 30, 2004 quarter and will decline by approximately an additional $11.3 million in the September 30, 2004 quarter.

 

Other income (net) of $3.1 million in the first quarter of 2004 included a gain on the sale of UMC shares (see Note 9) of $2.6 million, and $0.8 million interest and dividends on short term investments and cash equivalents, partially offset by $0.4 million of amortization of issuance costs on Zero Coupon Convertible Subordinated Notes due July 1, 2010To the extent market conditions allow, we may make similar sales of UMC shares in future quarters (see Note 12).  We are not currently paying federal or state income taxes and do not expect to pay or accrue such taxes in 2004.

 

12



 

Results of Operations

 

Key elements of our consolidated statement of operations, expressed as a percentage of revenues, were as follows:

 

 

 

Three Months Ended

 

 

 

Mar. 31, 2004

 

Mar. 31, 2003

 

 

 

 

 

 

 

Revenue

 

100.0

%

100.0

%

Gross margin

 

58.2

%

59.8

%

Research and development expenses

 

37.7

%

38.1

%

Selling, general and administrative expenses

 

22.2

%

21.8

%

Amortization of intangible assets

 

31.6

%

36.9

%

Loss from operations

 

(33.3

)%

(36.9

)%

 

Revenue:

 

Revenue for the first quarter of 2004 was $59.1 million, an increase of $1.8 million over the first quarter of 2003.  The composition of our revenue by product family for the first quarter of 2004 and the first quarter of 2003, respectively, was as follows:

 

 

 

Three Months Ended

 

 

 

Mar. 31, 2004

 

Mar. 31, 2003

 

 

 

 

 

 

 

FPGA

 

19

%

15

%

PLD (CPLD and SPLD)

 

81

%

85

%

 

As a percentage of revenue, U.S. sales rose to 33% for the first three months of 2004 as compared to 32% for the first three months of 2003.  Export sales to Asia rose as a percentage of revenue to 40% in the first three months of 2004 as compared to 32% in the first three months of 2003.  Export sales to Europe declined to 24% of revenue in the first three months of 2004 as compared to 30% in the first three months of 2003.

 

During the first quarter of 2004, total units sold declined two percent and average selling prices increased by five percent when compared to the first quarter of 2003. The decrease in units sold was attributable to lower sales of mature products. The increase in average selling price was primarily due to product mixSelling prices of semiconductor products generally decline over time. This decline is at times offset by higher selling prices of new products.  Our ability to achieve revenue growth is in large part dependent on the continued development, introduction and market acceptance of new products. See “Factors Affecting Future Results.”

 

Gross margin:

 

Our gross margin declined in the first quarter of 2004 to 58.2% from 59.8% in the first quarter of 2003 due to factors including lower than planned production yields and declining average selling prices on our new productsWe continuously endeavor to achieve reductions in overall manufacturing costs from on-going yield improvements, migration of products to more advanced technologies and reductions in wafer and assembly costs.

 

Research and development:

 

Research and development expenses increased $0.4 million in the first quarter of 2004 when compared to the first quarter of 2003.  Research and development expenses consist primarily of labor, masks, prototype wafers, third-party design automation software, assembly tooling and qualification expenses.  There were no significant cost changes in the major categories of research and development expense between the two quarters.

 

Selling, General and Administrative Expense:

 

Selling, general and administrative expenses were $13.1 million in the first quarter of 2004 (22.2% of revenue) as compared to $12.5 million in the first quarter of 2003 (21.8% of revenue).  The cost increase was primarily due to marketing expenses related to new products.

 

Amortization of Intangible Assets:

 

Amortization of intangible assets is related to our 2002 acquisitions of Agere FPGA and Cerdelinx, our 1999 Vantis acquisition and our 2001 acquisition of Integrated Intellectual Property, Inc. (“I2P”).  Amortization expense was

 

13



 

$18.7 million in the first quarter of 2004, compared to $21.1 million in the first quarter of 2003.  Nearly all ($2.2 million) of this decrease resulted from the accelerated write-off of accrued deferred compensation, recorded in conjunction with certain of our acquisitions, due to the cancellation of certain assumed in-the-money stock options as part of a stock option exchange program initiated during the first quarter of 2003 (see Note 11).  Amortization of intangible assets acquired in the Vantis acquisition will be completed during the June 2004 quarter.  As a result, amortization will decline by approximately $1.5 million in the June 2004 quarter and will decline by approximately an additional $11.3 million in the September 2004 quarter.

 

Other income (net):

 

Other income (net) of $3.1 million in the first quarter of 2004 included a gain on the sale of UMC shares (see Note 9) of $2.6 million, $0.8 million interest and dividends on short term investments and cash equivalents, partially offset by $0.4 million of amortization of issuance costs related to the Zero Coupon Convertible Subordinated Notes due July 1, 2010To the extent market conditions allow, we may make similar sales of UMC shares in future quarters (see Note 12).  We are not currently paying federal or state income taxes and do not expect to pay or accrue such taxes in 2004.

 

During the first quarter of 2003, we extinguished $32.8 million of our convertible subordinated notes for $29.9 million in cash, resulting in a gain of $2.9 million.  In conjunction with reducing our outstanding convertible debt from $208 million at the end of the 2002 to $175 million at the end of the first quarter of 2003, quarterly interest expense was reduced $0.4 million to $2.2 million.  This reduction, along with the $2.9 million gain discussed above, more than offset a reduction in interest income on invested balances caused by lower interest rates and a decrease in invested balances.

 

Benefit for income taxes:

 

No income taxes have been provided for in the first quarter of 2004 or 2003. This is the result of the following factors:

 

1)              We continued to experience significant losses during the first quarter of 2004 and 2003 and are currently not paying any significant income taxes;

 

2)              Net operating loss carry backs and credit carry backs available in prior periods are no longer available; and,

 

3)              In the fourth quarter of 2002, we recorded a $118.6 million charge to income tax expense, representing a valuation allowance on our recorded deferred tax assets, in accordance with SFAS 109, “Accounting for Income Taxes.” We provided a valuation allowance equal to our net deferred tax assets due to uncertainties regarding their realization. Due to continued uncertainties regarding their realization, we continue to provide a valuation allowance equal to our net deferred tax assets at March 31, 2004.

 

Goodwill and Purchased Intangible Assets

 

As a result of adopting SFAS 142 “Intangible Assets” in 2002, goodwill and certain intangibles with indefinite lives are no longer being amortized.To apply SFAS 142, a company is divided into separate “reporting units,” each representing groups of products that are separately managed.  For this purpose, we have one reporting unit.  To determine whether or not goodwill may be impaired, a test is required comparing the book value of the “reporting unit” to its trading price. Similar tests are required in the future, at least annually, and more often where there is a change in circumstances that could result in an impairment of goodwill.  If the trading price of our common stock is below the book value for a sustained period, a goodwill impairment test will be performed by comparing book value to estimated market value (trading price plus a control premium).  The excess of book value over estimated market value will then be subtracted from the goodwill account with a resulting charge to operations. Subsequent unrealized recoveries in market value, if any, will not be recorded.  We completed our annual goodwill impairment assessment in December 2003, upon which no impairment charge was recorded. Additional goodwill impairment tests will be performed at least annually.

 

14



 

The following tables present details of the Company’s total purchased intangible assets (in millions):

 

March 31, 2004

 

Gross

 

Accumulated
amortization

 

Net

 

 

 

 

 

 

 

 

 

Current technology

 

$

273.6

 

$

(227.8

)

$

45.8

 

Core technology

 

7.3

 

(2.3

)

5.0

 

Licenses

 

10.2

 

(3.2

)

7.0

 

Non-compete agreements

 

14.3

 

(10.3

)

4.0

 

Workforce

 

4.7

 

(1.5

)

3.2

 

Backlog

 

1.4

 

(1.4

)

 

Customer list

 

17.4

 

(16.7

)

0.7

 

Patents and trademarks

 

26.8

 

(25.7

)

1.1

 

 

 

 

 

 

 

 

 

Total

 

$

355.7

 

$

(288.9

)

$

66.8

 

 

December 31, 2003

 

Gross

 

Accumulated
amortization

 

Net

 

 

 

 

 

 

 

 

 

Current technology

 

$

273.6

 

$

(214.4

)

$

59.2

 

Core technology

 

7.3

 

(1.9

)

5.4

 

Licenses

 

10.2

 

(2.9

)

7.3

 

Non-compete agreements

 

14.3

 

(9.2

)

5.1

 

Workforce

 

4.7

 

(1.2

)

3.5

 

Backlog

 

1.4

 

(1.4

)

 

Customer list

 

17.4

 

(15.8

)

1.6

 

Patents and trademarks

 

26.8

 

(24.3

)

2.5

 

 

 

 

 

 

 

 

 

Total

 

$

355.7

 

$

(271.1

)

$

84.6

 

 

The estimated future amortization expense of purchased intangible assets as of March 31, 2004 is as follows (in millions):

 

Fiscal Year:

 

Amount

 

 

 

 

 

2004 (remaining nine months)

 

$

26.0

 

2005

 

14.4

 

2006

 

10.8

 

2007

 

9.8

 

2008

 

5.8

 

 

 

$

66.8

 

 

The estimated future amortization expense of deferred stock compensation attributable to Research and Development activities as of March 31, 2004 is $2.6 million for the remainder of 2004 and $1.9 million for 2005.

 

New Accounting Pronouncements

 

In January 2003, the Financial Accounting Standards Board (“FASB”) issued Financial Standards Accounting Board Interpretation (“FIN”) No. 46, “Consolidation of Variable Interest Entities,” an interpretation of Accounting Research Bulletin No. 51, “Consolidated Financial Statements.” FIN 46 establishes accounting guidance for consolidation of a variable interest entity.  In a variable interest entity the equity investors do not have a controlling interest or their equity interest is insufficient to finance the entity’s activities without receiving additional subordinated financial support from the other parties.  We do not currently have any business relationship with a variable interest entity, so the adoption of FIN 46 had no impact on our consolidated financial position or results of operations.

 

In May 2003, the FASB issued SFAS 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity.” This pronouncement establishes standards for how an issuer classifies and measures in its statement of financial position certain financial instruments with characteristics of both liabilities and equity. It

 

15



 

requires that an issuer classify a financial instrument that is within its scope as a liability (or an asset in certain circumstances) because that financial instrument embodies an obligation of the issuer. SFAS 150 is effective for financial instruments entered into or modified after May 31, 2003, and otherwise is effective for interim periods beginning after June 15, 2003.  On November 7, 2003, FASB issued FASB Staff Position No. FAS 150-3 (“FSP 150-3”), “Effective Date, Disclosures, and Transition for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests under FASB Statement No. 150, Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity.”  FSP 150-3 deferred certain aspects of SFAS 150.  The adoption of SFAS 150 and FSP 150-3 did not have a material impact on our results of operations, financial position or cash flows.

 

In March 2004, the Emerging Issues Task Force finalized its consensus on EITF Issue 03-6, “Participating Securities and the Two-Class Method Under FASB Statement No. 128, Earnings Per Share” ( EITF 03-6). EITF 03-6 clarifies what constitutes a participating security and requires the use of the two-class method for computing basic earnings per share when participating convertible securities exist. EITF 03-6 is effective for fiscal periods beginning after March 31, 2004. We are currently analyzing the impact of adoption of EITF 03-6 on our consolidated financial statements.

 

In April 2004, the Financial Accounting Standards Board issued FASB Staff Position (FSP)129-1, "Disclosure Requirements under FASB Statement 129, Disclosure of Information about Capital Structure, Relating to Contingently Convertible Securities," further defining disclosure requirements for convertible notes, among other things.  As a result of adopting FSP 129-1, we further described circumstances under which note holders may convert their notes into our common shares before note maturity.

 

Liquidity and Capital Resources

 

As of March 31, 2004, our principal source of liquidity was $298.5 million of cash and short-term investments, which was $20.8 million more than the balance of $277.8 million at December 31, 2003. Working capital increased to $380.7 million at March 31, 2004 from $363.6 million at December 31, 2003. This increase was primarily due to $13.0 million cash generated from operations.  During the first quarter of 2003 we generated $8.0 million of cash and cash equivalents from our operations and we spent $30.0 million to retire a portion of our convertible notes.

 

Accounts receivable days outstanding declined from approximately 46 to 40 days from December 31, 2003 to March 31, 2004 reflecting the timing of receipts within the period.  Inventories decreased by $2.3 million, or 5%, in the first quarter of 2004 primarily due to increasing customer shipments. Other current assets increased by $6.0 million at March 31, 2004 as compared to December 31, 2003 reflecting an increase in the amount of prepaid wafers expected to be used in the next twelve months and mark to market adjustments to equity securities available for sale primarily represented by the portion of our UMC investment that we expect to sell in the next 12 months (see Notes 9 and 12.)

 

Property and equipment, less accumulated depreciation, decreased by $2.5 million in the first quarter of 2004 due to depreciation exceeding expenditures for capital equipment. Foundry investments, advances and other assets decreased by $12.6 million from December 31, 2003 to March 31, 2004. This was primarily due to the reclassification of $8.8 million of our UMC investment to equity securities available for sale as described above and the reclassification of $4.6 million to Other current assets related to prepaid wafers described above, partially offset by a $0.9 million gain recorded in Accumulated other comprehensive (loss) income related to changes in the market value of our UMC shares.  Net intangible assets decreased by $17.8 million in the first quarter of 2004 which is attributable to amortization during the quarter.

 

Accounts payable and accrued expenses increased by $3.2 million at March 31, 2004 as compared to December 31, 2003 primarily related to amounts due to suppliers.  Deferred income increased by $3.3 million at March 31, 2004 as compared to December 31, 2003 reflecting an increase in the amount of inventory held by distributors.

 

Deferred Stock Compensation within Stockholders’ Equity decreased by $0.9 million during the first quarter of 2004 due to amortization.  The $1.2 million decrease in Accumulated Other Comprehensive Income within the Statement of Stockholders’ Equity during the first quarter of 2004 is attributable to the realized gain on sale of UMC securities partially offset by the unrealized gain in equity securities (see Note 9).

 

At March 31, 2004, we had no senior indebtedness and our subsidiaries had approximately $2.1 million of other liabilities. Issuance costs of $3.6 million, net of debt extinguishments, relative to our zero percent convertible subordinated notes are included in Other Assets in our Condensed Consolidated Balance Sheet and are being amortized to expense over the life of the notes. Accumulated amortization amounted to $1.8 million at March 31, 2004.  The estimated fair value of our convertible notes, based on quoted market prices, was approximately $189 million at the end of the March 31, 2004 quarter.  At the conversion price of  $12.06 per share (82.9105 shares of common stock per each $1,000 principal amount notes), 15.3 million common shares are issuable upon conversion.  In general, and as further described in the related agreements, the notes may be converted into common stock before

 

16



 

maturity if we request a redemption, make a distribution to common stock holders that is dilutive to note holders or if we become a party to a merger or consolidation or sale of substantially all of our assets.

 

We do not have any financial partnerships with unconsolidated entities, such as entities often referred to as structured finance or special purpose entities, which are often established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. Accordingly, we are not exposed to any financing, liquidity, market or credit risk that could arise if we had such relationships.

 

Capital expenditures were $2.0 million for the first quarter of 2004. We expect to spend approximately $15 million to $20 million for the fiscal year ending December 31, 2004.

 

At March 31, 2004, we own 81.7 million shares of UMC common stock.  Restrictions by UMC apply to approximately 28% of these shares (see Note 9). During the first three months of 2004, we sold 10.0 million of our UMC shares for  $9.2 million in cash, resulting in a gain of  $2.6 million.  In April 2004, we sold 10.0 million UMC shares for $9.6 million in cash resulting in a gain of $3.1 million.  In the future, we may or may not choose to liquidate additional UMC shares.

 

In December 2000, our Board of Directors authorized management to repurchase up to five million shares of our common stock. As of March 31, 2004, we had repurchased 1,136,000 shares at an aggregate cost of $20.0 million. There were no repurchases of common stock in 2002, 2003 or the first quarter of 2004.

 

In March 1997 and as subsequently amended in January 2002 and March 2004, we entered into an advance payment production agreement with Seiko Epson and Epson Electronics America, Inc.  (“EEA”) under which we advanced  $51.3 million to Seiko Epson to finance construction of an eight-inch sub-micron semiconductor wafer manufacturing facility.  Under the terms of the agreement, the advance is to be repaid with semiconductor wafers over a multi-year period.  No interest income is recorded.  The agreement calls for wafers to be supplied by Seiko Epson through EEA pursuant to purchase agreements with EEA.  Cumulatively, $16.6 million of these payments have been repaid to us in the form of semiconductor wafers.   We currently estimate that approximately $13.5 million of the outstanding advances are expected to be repaid with semiconductor wafers during the next twelve months and are thus reflected as part of Other current assets in our Consolidated Balance Sheet.   We are not obligated to make additional payments under this agreement.

 

On March 22, 2004 we announced that Fujitsu Limited (“Fujitsu”) has agreed to manufacture our next generation FPGA products on its 130-nanometer (nm) and 90-nanometer CMOS process technologies, as well as on a 130-nm technology with embedded Flash memory that we have jointly developed with Fujitsu.  Additionally we announced plans which contemplate investing in stages before the end of 2005 between $100 million to $200 million in Fujitsu’s new 300mm wafer fab and structuring the investment as an advance payment for production wafers and access to future process technologies.

 

We believe that our existing liquid resources, expected cash generated from operations and existing credit facilities combined with our ability to borrow additional funds will be adequate to meet our operating and capital requirements and obligations for the next 12 months, including the continued possible extinguishment of a portion of our convertible subordinated notes as discussed above.

 

We may in the future seek new or additional sources of funding. In addition, in order to secure additional wafer supply, we may from time to time consider various financial arrangements including joint ventures, equity investments, advance purchase payments, loans, or similar arrangements with independent wafer manufacturers in exchange for committed wafer capacity. To the extent that we pursue any such additional financing arrangements, additional debt or equity financing may be required. There can be no assurance that such additional financing will be available when needed or, if available, will be on favorable terms. Any future equity financing will decrease existing stockholders’ equity percentage ownership and may, depending on the price at which the equity is sold, result in dilution.

 

 

FACTORS AFFECTING FUTURE RESULTS

 

A downturn in the communications equipment and computing end markets has caused a reduction in demand for our products and limited our ability to maintain or increase revenue levels and operating results.

 

A significant portion of our revenue is derived from customers in the communications equipment and computing end markets.  Due to deterioration in overall economic conditions and a significant reduction in information technology capital spending, the communications and computing end markets have experienced a significant and

 

17



 

prolonged downturn. While economic conditions in general, and the communications and computer end markets in particular, have recently shown signs of improvement, the improved conditions may not continue or lead to improved demand for our products.  Whenever adverse economic or end market conditions exist, there is likely to be an adverse effect on our operating results.

 

We may be unsuccessful in defining, developing or selling new products required to maintain or expand our business.

 

As a semiconductor company, we operate in a dynamic environment marked by rapid product obsolescence.  Our future success depends on our ability to introduce new or improved silicon and software products that meet customer needs while achieving acceptable margins.  If we fail to introduce these new products in a timely manner or these products fail to achieve market acceptance, our operating results would be harmed.

 

The introduction of new silicon and software products in a dynamic market environment presents significant business challenges.  Product development commitments and expenditures must be made well in advance of product sales.  The market reception of new products depends on accurate projections of long-term customer demand, which by their nature are uncertain.

 

Our future revenue growth is dependent on market acceptance of our new silicon and software product families and the continued market acceptance of our current products.  The success of these products is dependent on a variety of specific technical factors including:

 

                  successful product definition;

 

                  timely and efficient completion of product design;

 

                  timely and efficient implementation of wafer manufacturing and assembly processes;

 

                  product performance;

 

                  product cost; and

 

                  the quality and reliability of the product.

 

If, due to these or other factors, our new silicon and software products do not achieve market acceptance, our operating results would be harmed.

 

In March 2004, we announced that Fujitsu Limited has agreed to manufacture our next generation FPGA products on its 130 nanometer and 90 nanometer CMOS process technologies, as well as on a 130 nanometer technology with embedded Flash memory that we have jointly developed with Fujitsu.  The success of our future product launches is dependent on our ability to successfully partner with Fujitsu, which has not previously manufactured any of our products.  If for any reason we are unsuccessful in our efforts to partner with Fujitsu in connection with these future product launches, our future revenue growth will be materially adversely affected.

 

The cyclical nature of the semiconductor industry may limit our ability to maintain or increase revenue levels and operating results during current or future industry downturns.

 

The semiconductor industry is highly cyclical, to a greater extent than other less technology-driven industries.  Our financial performance has periodically been negatively affected by downturns in the semiconductor industry.  Factors that contribute to these industry downturns include:

 

                  the cyclical nature of the demand for the products of semiconductor customers;

 

                  general reductions in inventory levels by customers;

 

                  excess production capacity;

 

                  general decline in end-user demand; and

 

                  accelerated declines in average selling prices.

 

Beginning in 2001, the semiconductor industry experienced a downturn of extreme severity and duration.  While semiconductor industry conditions recently have improved, the improvement may not be significant or sustainable.  Increased demand for semiconductor industry products may not proportionately increase demand for programmable

 

18



 

logic market segment products in general, or our products in particular.  Even if demand for our products increases, average sales prices for our products may not increase, and could decline.  Whenever adverse semiconductor industry conditions or other similar conditions exist, there is likely to be an adverse effect on our operating results.

 

Our products may not be competitive if we are unsuccessful in migrating our manufacturing processes to more advanced technologies or alternative fabrication facilities.

 

To develop new products and maintain the competitiveness of existing products, we need to migrate to more advanced wafer manufacturing processes that use larger wafer sizes and smaller device geometries.  We also may need to use additional foundries.  Because we depend upon foundries to provide their facilities and support for our process technology development, we may experience delays in the availability of advanced wafer manufacturing process technologies at existing or new wafer fabrication facilities.  As a result, volume production of our advanced process technologies at the fabs of Seiko Epson, UMC, Chartered Semiconductor, Fujitsu or future foundries may not be achieved.  This could harm our operating results.

 

We face risks related to our recent accounting restatement.

 

On January 22, 2004, we announced that we had discovered possible accounting inaccuracies in previously reported quarterly financial statements. An internal investigation was conducted by the Audit Committee of our Board of Directors to determine the scope and magnitude of these inaccuracies. On March 24, 2004, we announced that the Audit Committee had completed its internal accounting investigation and, as a result, we restated our financial statements for the first, second and third quarters of 2003 to correct inappropriate accounting entries and a failure to record a change in accounting estimate related to deferred income.  On April 19, 2004, we filed such restated financial statements with Form 10Q/A for the affected quarters.

 

The restatement of these financial statements may lead to litigation claims and/or regulatory proceedings against us.  The defense of any such claims or proceedings may cause the diversion of management’s attention and resources, and we may be required to pay damages if any such claims or proceedings are not resolved in our favor. Any litigation or regulatory proceeding, even if resolved in our favor, could cause us to incur significant legal and other expenses.  Moreover, we may be the subject of negative publicity focusing on the financial statement inaccuracies and resulting restatement.  The occurrence of any of the foregoing could harm our business and reputation and cause the price of our common stock to decline.

 

If we are unable to effectively and efficiently implement our plan to remediate a material weakness that has been identified in our internal controls and procedures, there could be a material adverse effect on our operations or financial results.

 

We received notice from our independent auditor that, in connection with the 2003 year-end audit, the auditor has identified a material weakness in our internal controls and procedures relating to separation of duties and establishment of standards for review of journal entries and related file documentation.  We have implemented and are continuing to implement various initiatives intended to materially improve our internal controls and procedures to address this weakness.  These initiatives address our control environment, organization and staffing, policies, procedures and documentation, and information systems. The implementation of these initiatives is one of our highest priorities. Our Board of Directors, in coordination with our Audit Committee, will continually assess the progress and sufficiency of these initiatives and make adjustments as necessary. However, no assurance can be given that we will be able to successfully implement our revised internal controls and procedures or that our revised controls and procedures will be effective in remedying all of the identified deficiencies in our internal controls and procedures. In addition, we may be required to hire additional employees, and may experience higher than anticipated capital expenditures and operating expenses, during the implementation of these changes and thereafter. If we are unable to implement these changes effectively or efficiently, there could be a material adverse effect on our operations or financial results.  Moreover, we could be subject to additional regulatory oversight and our business and reputation could be harmed.

 

In addition, we may in the future experience accounting estimate changes related to our deferred income account, inventory account, income tax liability, accounts receivable collectibility, or realization of goodwill and intangible assets, any of which could adversely affect our financial results.

 

Our future quarterly operating results may fluctuate and therefore may fail to meet expectations.

 

Our quarterly operating results have fluctuated and may continue to fluctuate.  Consequently, our operating results may fail to meet the expectations of analysts and investors.  As a result of industry conditions and the following specific factors, our quarterly operating results are more likely to fluctuate and are more difficult to predict than a typical non-technology company of our size and maturity:

 

19



 

                  general economic conditions in the countries where we sell our products;

 

                  conditions within the end markets into which we sell our products;

 

                  the cyclical nature of demand for our customers’ products;

 

                  excessive inventory accumulation by our end customers;

 

                  the timing of our and our competitors’ new product introductions;

 

                  product obsolescence;

 

                  the scheduling, rescheduling and cancellation of large orders by our customers;

 

                  our ability to develop new process technologies and achieve volume production at the fabs of Seiko Epson, UMC, Chartered Semiconductor, Fujitsu or at other foundries;

 

                  changes in manufacturing yields;

 

                  adverse movements in exchange rates, interest rates or tax rates; and

 

                  the availability of adequate supply commitments from our wafer foundries and assembly and test subcontractors.

 

As a result of these factors, our past financial results are not necessarily a good predictor of our future results.

 

Our stock price may continue to experience large fluctuations.

 

In recent years, the price of our common stock has fluctuated greatly.  These price fluctuations have been rapid and severe and have left investors little time to react.  The price of our common stock may continue to fluctuate greatly in the future due to a variety of company specific factors, including:

 

                  quarter-to-quarter variations in our operating results;

 

                  shortfalls in revenue or earnings from levels expected by securities analysts; and

 

                  announcements of technological innovations or new products by other companies.

 

Presently, our stock price is trading near our consolidated book value. A sustained decline in our stock price may result in a write-off of goodwill (see Note 1 of our Consolidated Financial Statements).

 

Our wafer supply may be interrupted or reduced, which may result in a shortage of finished products available for sale.

 

We do not manufacture finished silicon wafers.  Currently, substantially all of our silicon wafers are manufactured by Seiko Epson in Japan, UMC in Taiwan, and Chartered Semiconductor in Singapore.  In March 2004 we announced that we will also be sourcing wafers on advanced process technologies from Fujitsu in Japan. If any of our current or future foundry partners significantly interrupts or reduces our wafer supply, our operating results could be harmed.

 

In the past, we have experienced delays in obtaining wafers and in securing supply commitments from our foundries.  At present, we anticipate that our supply commitments are adequate.  However, these existing supply commitments may not be sufficient for us to satisfy customer demand in future periods.  Additionally, notwithstanding our supply commitments we may still have difficulty in obtaining wafer deliveries consistent with the supply commitments.  We negotiate wafer prices and supply commitments from our suppliers on at least an annual basis.  If any of our foundry partners were to reduce its supply commitment or increase its wafer prices, and we cannot find alternative sources of wafer supply, our operating results could be harmed.

 

Many other factors that could disrupt our wafer supply are beyond our control.  Since worldwide manufacturing capacity for silicon wafers is limited and inelastic, we could be harmed by significant industry-wide increases in overall wafer demand or interruptions in wafer supply.  Additionally, a future disruption of any of our foundry partners’ foundry operations as a result of a fire, earthquake or other natural disaster could disrupt our wafer supply and could harm our operating results.

 

20



 

If our foundry partners experience quality or yield problems, we may face a shortage of finished products available for sale.

 

We depend on our foundries to deliver reliable silicon wafers with acceptable yields in a timely manner.  As is common in our industry, we have experienced wafer yield problems and delivery delays.  If our foundries are unable for a prolonged period to produce silicon wafers that meet our specifications, with acceptable yields, our operating results could be harmed.

 

The majority of our revenue is derived from products based on a specialized silicon wafer manufacturing process technology called E²CMOS®.  The reliable manufacture of high performance E²CMOS semiconductor wafers is a complicated and technically demanding process requiring:

 

                  a high degree of technical skill;

 

                  state-of-the-art equipment;

 

                  the absence of defects in the masks used to print circuits on a wafer;

 

                  the elimination of minute impurities and errors in each step of the fabrication process; and

 

                  effective cooperation between the wafer supplier and us.

 

As a result, our foundries may experience difficulties in achieving acceptable quality and yield levels when manufacturing our silicon wafers.

 

If our assembly and test contractors experience quality or yield problems, we may face a shortage of finished products available for sale.

 

We rely on contractors to assemble and test our devices with acceptable quality and yield levels.  As is common in our industry, we have experienced quality and yield problems in the past.  If we experience prolonged quality or yield problems in the future, our operating results could be harmed.

 

The majority of our revenue is derived from semiconductor devices assembled in advanced packages.  The assembly of advanced packages is a complex process requiring:

 

                  a high degree of technical skill;

 

                  state-of-the-art equipment;

 

                  the absence of defects in lead frames used to attach semiconductor devices to the package;

 

                  the elimination of raw material impurities and errors in each step of the process; and

 

                  effective cooperation between the assembly contractor and us.

 

As a result, our contractors may experience difficulties in achieving acceptable quality and yield levels when assembling and testing our semiconductor devices.

 

Deterioration of conditions in Asia may disrupt our existing supply arrangements and result in a shortage of finished products available for sale.

 

All of our major silicon wafer suppliers operate fabs located in Asia.  Our finished silicon wafers are assembled and tested by independent contractors located in China, Malaysia, the Philippines, South Korea and Taiwan. A prolonged interruption in our supply from any of these contractors could harm our operating results.

 

Economic, financial, social and political conditions in Asia have historically been volatile.  Financial difficulties, governmental actions or restrictions, prolonged work stoppages or any other difficulties experienced by our suppliers may disrupt our supply and could harm our operating results.

 

Our wafer purchases from Seiko Epson are denominated in Japanese yen.  The value of the dollar with respect to the yen fluctuates.  Substantial deterioration of dollar-yen exchange rates could harm our operating results.

 

21



 

Export sales account for a substantial portion of our revenues and may decline in the future due to economic and governmental uncertainties.

 

Our export sales are affected by unique risks frequently associated with foreign economies including:

 

                  changes in local economic conditions;

 

                  exchange rate volatility;

 

                  governmental controls and trade restrictions;

 

                  export license requirements and restrictions on the export of technology;

 

                  political instability or terrorism;

 

                  changes in tax rates, tariffs or freight rates;

 

                  interruptions in air transportation; and

 

                  difficulties in staffing and managing foreign sales offices.

 

For example, our export sales have historically been affected by regional economic crises.  Significant changes in the economic climate in the foreign countries where we derive our export sales could harm our operating results.

 

We may not be able to successfully compete in the highly competitive semiconductor industry.

 

The semiconductor industry is intensely competitive and many of our direct and indirect competitors have substantially greater financial, technological, manufacturing, marketing and sales resources.  If we are unable to compete successfully in this environment, our future results will be adversely affected.

 

The current level of competition in the programmable logic market is high and may increase in the future. We currently compete directly with companies that have licensed our technology or have developed similar products.  We also compete indirectly with numerous semiconductor companies that offer products and solutions based on alternative technologies.  These direct and indirect competitors are established multinational semiconductor companies as well as emerging companies.  We also may experience significant competition from foreign companies in the future.

 

We may fail to retain or attract the specialized technical and management personnel required to successfully operate our business.

 

To a greater degree than most non-technology companies or larger technology companies, our future success depends on our ability to attract and retain highly qualified technical and management personnel.  As a mid-sized company, we are particularly dependent on a relatively small group of key employees.  Competition for skilled technical and management employees is intense within our industry.  As a result, we may not be able to retain our existing key technical and management personnel.  In addition, we may not be able to attract additional qualified employees in the future.  If we are unable to retain existing key employees or are unable to hire new qualified employees, our operating results could be adversely affected.

 

If we are unable to adequately protect our intellectual property rights, our financial results and competitive position may suffer.

 

Our success depends in part on our proprietary technology.  However, we may fail to adequately protect this technology. As a result, we may lose our competitive position or face significant expense to protect or enforce our intellectual property rights.

 

We intend to continue to protect our proprietary technology through patents, copyrights and trade secrets.  Despite this intention, we may not be successful in achieving adequate protection.  Claims allowed on any of our patents may not be sufficiently broad to protect our technology.  Patents issued to us also may be challenged, invalidated or circumvented.  Finally, our competitors may develop similar technology independently.

 

Companies in the semiconductor industry vigorously pursue their intellectual property rights.  If we become involved in protracted intellectual property disputes or litigation we may utilize substantial financial and management resources, which could have an adverse effect on our operating results.

 

22



 

Our industry is characterized by frequent claims regarding patents and other intellectual property rights of others. We have been, and from time-to-time expect to be, notified of claims that we are infringing the intellectual property rights of others. If any third party makes a valid claim against us, we could face significant liability and could be required to make material changes to our products and processes. In response to any claims of infringement, we may seek licenses under patents that we are alleged to be infringing. However, we may not be able to obtain a license on favorable terms or without our operating results being adversely affected.

 

Our marketable securities, which we hold for strategic reasons, are subject to equity price risk and their value may fluctuate.

 

Currently we hold substantial equity in UMC, which we acquired as part of a strategic investment to obtain certain manufacturing rights.  The market price and valuation of these equity shares has fluctuated widely due to market and other conditions over which we have little control.  During the year ended December 31, 2001, we recorded a $152.8 million pre-tax impairment loss related to this investment.  In the future, UMC shares may continue to experience significant price volatility. In the second quarter of 2002 and the first and second quarters of 2004, we sold a portion of our UMC shares, but have otherwise not attempted to reduce or eliminate this equity price risk through hedging or similar techniques and hence substantial, sustained changes in the market price of UMC shares could impact our financial results.  To the extent that the market value of our UMC shares experiences a significant decline for an extended period of time, our net income could be reduced.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

There have been no material changes from what we reported in the Form 10K Annual Report for the year ended December 31, 2003.

 

Item 4. Controls and Procedures

 

This portion of our quarterly report is our disclosure of the conclusions of our management, including our Chief Executive Officer and Chief Financial Officer, regarding the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report, based on management’s evaluation of those disclosure controls and procedures. You should read this disclosure in conjunction with the certifications attached as Exhibit 31.1 and 31.2 to this annual report for a more complete understanding of the topics presented.

 

 In January 2004, the Audit Committee of our Board of Directors, with the assistance of outside legal counsel and our independent auditor, commenced an internal investigation of the facts and circumstances surrounding inappropriate journal entries affecting the deferred income and accrued expense accounts. As a result of the investigation, it was determined that the unaudited consolidated condensed financial statements for each of the three month periods ended September 30, 2003, June 30, 2003 and March 31, 2003 required restatement.

 

After reviewing the restatement adjustments and performing an evaluation of our controls and disclosure procedures, management concurred with the Audit Committee that improvements to internal controls are needed relating to: (1) separation of duties and (2) establishment of standards for review and approval of journal entries as well as related file documentation.

 

We received notice from our independent auditor that, in connection with the 2003 year-end audit, the auditor had identified a material weakness relating to our internal controls and procedures. Certain of these internal control deficiencies may also constitute deficiencies in our disclosure controls. While we are in the process of implementing a more effective system of controls and procedures, we have instituted controls, procedures and other changes to ensure that information required to be disclosed in this quarterly report on Form 10-Q has been recorded, processed, summarized and reported accurately.

 

The incremental steps that we have taken as a result of the aforementioned control deficiencies to ensure that all material information about our company is accurately disclosed in this report include:

 

1. Performed an analytical review of all journal entries processed for the 2003 year and March 2004 quarter;

 

2. Applied additional methods and techniques to evaluate the accuracy of the deferred income account balance;

 

3. Instituted an additional level of approval for non recurring journal entries;

 

4. Strengthened segregation of duties by adding an additional level of review for authorization and review of significant transactions; and

 

23



 

5. Made appropriate personnel changes.

 

Based in part on the steps listed above, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are effective to ensure that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported accurately within the time periods specified in Securities and Exchange Commission rules and forms.

 

In addition, in order to address further the deficiencies described above and to improve our internal disclosure and control procedures for future periods, we will:

 

1. Review, select and implement available improvements to information systems for distribution accounting;

 

2. Separate responsibilities for preparing financial statements and maintaining accounts in the company’s general ledger;

 

3. Perform a review of internal controls and procedures in connection with Section 404 of Sarbanes Oxley legislative requirements;

 

4. Perform more detailed quarterly reconciliations and analyses of the company’s deferred revenue accounts related to its distributors;

 

5. Enhance quarterly accounting review procedures requiring an independent review of material general ledger accounts;

 

6. Require all non recurring journal entries to be approved by an independent reviewer; and

 

7. Enhance staffing to provide sufficient resources to accomplish the foregoing objectives.

 

These steps will constitute significant changes in internal controls. We will continue to evaluate the effectiveness of our disclosure controls and internal controls and procedures on an ongoing basis, and will take further action as appropriate.

 

PART II.   OTHER INFORMATION

 

Item 2. Changes in Securities, Use of Proceeds, and Issue Purchases of Equity Securities

 

In December 2000, our Board of Directors authorized management to repurchase up to five million shares of our common stock. As of March 31, 2004, we had repurchased 1,136,000 shares at an aggregate cost of $20.0 million. There were no repurchases of common stock in 2002, 2003 or the first quarter of 2004.

 

Item 6. Exhibits and Reports on Form 8-K

 

(a)

 

Exhibits

 

 

 

 

 

10.42                     Amendment dated March 25, 2004 to Advance Production Payment Agreement dated March 17, 1997, as previously amended, among Lattice Semiconductor Corporation and Seiko Epson Corporation and S MOS Systems, Inc. (1).

 

 

 

 

 

31.1                           Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.

 

 

 

 

 

31.2                           Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.

 

 

 

 

 

32.1                           Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18  U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

24



 

(b)                                 Reports on Form 8-K

 

The following reports on Form 8-K were filed during the quarter ended March 31, 2004

 

On March 24, 2004, we filed a Current Report on Form 8-K which included a press release of the same date,  reporting our financial results for the fourth quarter and year ended December 31, 2003.

 

On March 24, 2004 we filed a Current Report on Form 8-K announcing that Fujitsu Limited (“Fujitsu”) has agreed to manufacture our next generation FPGA products on its 130-nanometer (nm) and 90-nanometer CMOS process technologies, as well as on a 130-nm technology with embedded Flash memory that we have jointly developed with Fujitsu.  Additionally we announced plans which contemplate investing in stages before the end of 2005 between $100 million to $200 million in Fujitsu’s new 300mm wafer fab and structuring the investment as an advance payment for production wafers and for access to future process technologies.

 

On March 19, 2004 we filed a Current Report on Form 8-K, which included a press release dated March 18, 2004 announcing a delay in releasing our financial results for the year and quarter ended December 31, 2003 and an anticipated restatement of the first, second and third quarter of 2003 financial results.

 

 


(1)                                  Pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, confidential treatment has been requested for portions of this exhibit, which portions have been deleted and filed separately with the Securities and Exchange Commission.

 

25



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

LATTICE SEMICONDUCTOR CORPORATION (Registrant)

 

Date: May 12, 2004

 

 

By:

/s/ Jan Johannessen

 

 

Jan Johannessen

 

Corporate Vice President and Chief Financial Officer

 

26